Rachael F Grace Selected Research

Splenectomy

4/2021	Comorbidities and complications in adults with pyruvate kinase deficiency.
1/2021	Pyruvate kinase deficiency in children.
9/2015	Erythrocyte pyruvate kinase deficiency: 2015 status report.
7/2009	Compliance with immunizations in splenectomized individuals with hereditary spherocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachael F Grace Research Topics

Disease

26	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2022 - 07/2010
14	Hemorrhage 01/2021 - 08/2015
11	Pyruvate Kinase Deficiency of Red Cells 01/2022 - 01/2018
8	Hemolytic Anemia 04/2021 - 01/2018
5	Thrombocytopenia (Thrombopenia) 11/2022 - 01/2018
5	Hemolysis 01/2022 - 03/2012
5	Thrombosis (Thrombus) 04/2021 - 02/2011
4	Iron Overload 10/2020 - 04/2012
3	Chronic Disease (Chronic Diseases) 01/2022 - 01/2019
3	Fatigue 01/2022 - 10/2020
3	Cytopenia 06/2021 - 01/2015
3	Gallstones (Gallstone) 10/2020 - 01/2018
2	Headache (Headaches) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2022 - 02/2011
2	Anemia 01/2022 - 09/2015
2	Evans Syndrome 08/2021 - 01/2019
2	Pulmonary Hypertension 04/2021 - 10/2020
2	Infections 01/2021 - 07/2009
2	Congenital Nonspherocytic Hemolytic Anemia (Anemia, Hemolytic Congenital, Nonspherocytic) 10/2020 - 01/2018
2	Hereditary Spherocytosis 08/2014 - 07/2009
1	Immune System Diseases (Immune Disorders) 11/2022
1	Primary Immunodeficiency Diseases 11/2022
1	Nausea 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2021
1	Osteoporosis 04/2021
1	Compartment Syndromes 01/2021
1	Sepsis (Septicemia) 01/2021
1	COVID-19 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Disease Progression 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	acquired Thrombotic thrombocytopenic purpura 07/2018
1	Hypersensitivity (Allergy) 07/2018
1	Thrombotic Microangiopathies 07/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2018
1	Glucosephosphate Dehydrogenase Deficiency 01/2018
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 01/2018
1	Neonatal Jaundice 01/2018
1	Hereditary Elliptocytosis 07/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 02/2010
1	Pathologic Constriction (Stenosis) 02/2010

Drug/Important Bio-Agent (IBA)

26	Inosine Triphosphate (ITP)IBA 11/2022 - 07/2010
6	Pyruvate KinaseIBA 01/2022 - 01/2018
5	Rituximab (Mabthera)FDA Link 01/2022 - 02/2012
5	EnzymesIBA 01/2021 - 01/2018
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
4	Thrombopoietin ReceptorsIBA 01/2022 - 10/2015
3	IronIBA 01/2022 - 04/2012
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2021
2	mitapivatIBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2016
2	romiplostim FDA Link 01/2020 - 01/2019
2	Rho(D) Immune Globulin (RhoGAM)IBA 01/2019 - 03/2012
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2018
2	Asparaginase (Elspar)FDA Link 02/2018 - 02/2011
1	Immunomodulating AgentsIBA 06/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	HexokinaseIBA 01/2021
1	AnticoagulantsIBA 01/2021
1	VaccinesIBA 01/2021
1	BilirubinIBA 10/2020
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	thiamine triphosphorate (TTP)IBA 07/2018
1	ofatumumab FDA Link 07/2018
1	ADAMTS13 ProteinIBA 07/2018
1	AntibodiesIBA 07/2018
1	Monoclonal AntibodiesIBA 07/2018
1	PAR-1 ReceptorIBA 08/2015
1	Glycoproteins (Glycoprotein)IBA 08/2015
1	Thrombin Receptors (Thrombin Receptor)IBA 08/2015
1	P-SelectinIBA 08/2015
1	Platelet Membrane Glycoprotein IIbIBA 08/2015
1	thrombin receptor peptide SFLLRNPIBA 08/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2015
1	Erythropoietin FDA Link 08/2014
1	4,5- dihydro- 2- (2- hydroxy- 3- (3,6,9- trioxadecyloxy)phenyl)- 4- methyl- 4- thiazolecarboxylic acidIBA 04/2012
1	Chelating AgentsIBA 04/2012
1	Immunoglobulins (Immunoglobulin)IBA 03/2012
1	RHO(D) antibody (anti-D)IBA 03/2012
1	SteroidsIBA 02/2012
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2010

Therapy/Procedure

15	Therapeutics 01/2022 - 02/2012
4	Splenectomy 04/2021 - 07/2009
1	Cholecystectomy 04/2021
1	Activities of Daily Living (ADL) 12/2018
1	Consolidation Chemotherapy 02/2018
1	Phototherapy (Light Therapy) 09/2015